Foundation for innovation
in Cardiometabolism and Nutrition

Videos

IHU ICAN, a center of scientific excellence against cardiometabolic diseases

IHU ICAN institutional video: who are we? (English version)

Heading toward 2026 for IHU ICAN: research is accelerating!

France 2030: essential support for the health of tomorrow in cardiometabolism

National Cardiometabolic Diseases Week: everyone is concerned!

What is an IHU? (English version)

Cardiometabolism, a public health challenge

Cardiometabolic diseases explained by Prof. Hatem

“1 million hospitalizations are due to cardiometabolic diseases” | Dr Caroline Semaille

“Cardiometabolic diseases concern everyone, at any time” | Prof. Stéphane Hatem

The French Health Insurance system facing the explosion of cardiometabolic diseases | Dr Catherine Grenier

Cardiometabolic diseases: “diagnostic tools are improving” | Prof. Etienne Gayat

“What dialogue between organs? Liver, heart, kidney, adipose tissue, brain…” | Prof. Vlad Ratziu

Focus on major projects

The ICONIC project: the first cardiac and liver imaging atlas in the general population

The MAESTRIA project: artificial intelligence serving innovation (English version)

The PEGASE project: a major breakthrough in heart transplantation

Technological platforms

Discover the installation of the research MRI on the ICAN Imaging platform

ICAN BioCell Human Liver Biology platform: research on chronic liver diseases

ICAN BioCell iPS platform: production and genetic modification of iPS cells

Replay of our conferences

Conference at the Ministry of Health “Prevention of cardiometabolic diseases”: PART 1/2

Conference at the Ministry of Health “Prevention of cardiometabolic diseases”: PART 2/2

Conference at the French National Academy of Medicine “Cardiometabolic diseases: everyone is concerned”: PART 1/2

Conference at the French National Academy of Medicine “Cardiometabolic diseases: everyone is concerned”: PART 2/2

Conference at the Council of State “AI and big data”: PART 1/2

Conference at the Council of State “AI and big data”: PART 2/2

Support research with us

Why support IHU ICAN?

Donor testimonial: TRIOMPHE DU COEUR supports IHU ICAN

“Biomedical research must be funded at a level very different from the current one” | Prof. Boitard

Cardiovascular diseases

Cardiac rehabilitation: what role does physical activity play?

Coronary CT scan: how does the examination take place?

Cardiomyopathies: how can genetic diagnosis be improved?

Hereditary heart diseases: a project to support adolescents and young adults

Cardio-immunology: what advances in research?

Computational Fluid Dynamics Analysis of Left Atrial Blood Flow in Patients with Atrial Fibrillation (English version)

MASH (metabolic steatohepatitis)

REPLAY: Webinar | MASH (“fatty liver disease”), multidisciplinary care is essential

The MASH clinic: a unique care pathway in France against “fatty liver disease”

MASLD: what role do mitochondrial dysfunctions play in metabolic fatty liver disease?

Obesity and nutrition

REPLAY: Webinar | Obesity: patient testimony, care management, and metabolic risks

What impact does maternal obesity have on postnatal cardiac development? (OB-MAT project)

“Medications against obesity are a revolution” | Prof. Judith Aron-Wisnewsky

Obesity: “for our children, prevention and protection are imperative” | Anne-Sophie Joly

Overweight and obesity: how can we avoid other cardiometabolic diseases?

Nutrition and cardiometabolism: 5 questions for a nutritionist

Diabetes

REPLAY: Webinar | Type 2 diabetes and cardiovascular complications

Diabetes: “the level of prescription of medications is insufficient” | Dr Jean-François Thébaut

Living with diabetes: testimony from a patient with type 1 diabetes

Type 2 diabetes: causes, diagnosis, treatments

Type 1 diabetes: causes, diagnosis, treatments

Microbiota, bariatric surgery: what impacts on type 2 diabetes?

What role does the intestine play in the treatment of type 2 diabetes?

Research on type 1 diabetes: what advances?

The diabetic foot: complications and management

What care pathway for type II diabetes?

Climbing a 7,000 m summit: the ambitious challenge of a patient with diabetes

Familial hypercholesterolemia

REPLAY: Webinar | Homozygous and heterozygous familial hypercholesterolemia

IDEAL-HFHo, a research project against a rare genetic disease: homozygous FH

What is familial hypercholesterolemia? 1 in 250 people in France are affected

What treatments are available for familial hypercholesterolemia?

LDL apheresis treatment for familial hypercholesterolemia

Follow Georges in day hospital! Familial hypercholesterolemia

A family affected by familial hypercholesterolemia: Nathalie’s testimony

Living young with familial hypercholesterolemia: Luigi’s testimony

Where does research on familial hypercholesterolemia stand?

Interview with the ANHET association for FH Week 2022

What is hypercholesterolemia?

Training / education

Launch of the University Diploma “Health and Cardiometabolic Diseases” (Prof. Vlad Ratziu & Prof. Stéphane Hatem)

Doctoral student or post-doc? Join the IHU ICAN Summer Camp! (English version)

Lipidomics as a powerful tool for clinical studies (English version)

“`

ISO 9001 Certified

OUr Institutionnal Supporters

Our network